Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats. [electronic resource]
- Toxicology and applied pharmacology Aug 2011
- 267-79 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2011.04.019 doi
Animals Benzamides Bone Development--drug effects Bone Resorption--chemically induced Imatinib Mesylate Male Osteogenesis--drug effects Piperazines--pharmacology Protein Kinase Inhibitors--pharmacology Pyrimidines--pharmacology Rats Rats, Sprague-Dawley Receptor Protein-Tyrosine Kinases--antagonists & inhibitors